Male circumcision

Published: 07 April 2009
  • There is good evidence that in African settings, circumcision protects men against HIV infection.
  • Circumcision has less benefit to gay men, who are more likely to acquire HIV through receptive sex than insertive sex.

There is strong biological and epidemiological evidence that circumcised men are less vulnerable to HIV infection via heterosexual intercourse than uncircumcised men.

Circumcision is believed to reduce the risk of male infection because it removes the vulnerable tissue inside the foreskin, which contains Langerhans cells (a type of cell particularly vulnerable to HIV infection). The mucosa that covers the inside of the foreskin contains more Langerhans cells than almost any other part of the body except the gut. These are a type of dendritic cell whose job is to ferry foreign particles to the lymph nodes for recognition by the immune system, and which HIV hijacks as part of its infection strategy. In ex-vivo explant models, foreskin mucosa was found to be nine times more vulnerable to HIV infection than cervical tissue.

The area under the foreskin is also vulnerable to trauma, and is more likely to become abraded if sufficient lubrication is not present. Also, uncircumcised men may be more vulnerable to sexually transmitted infections (STIs), because the area under the foreskin can retain bacteria acquired during sex, thus increasing the chance that an infection will become established.

In Africa, the countries where less than 20% of the male population is circumcised form a broad swathe extending from the Central African Republic and southern Sudan in the north, through the former British colonies of east Africa, and down to Botswana, Zimbabwe and Swaziland.1 The only country that has high (>10%) levels of HIV prevalence but also higher circumcision levels than 20% is South Africa, whose very mixed cultural, sexual and racial background may make it a special case.

References

  1. Halperin D et al. Male circumcision and HIV infection: 10 years and counting. Lancet 354:1813-1815, 1999
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.